ZA898605B - Compositions for topical treatment of skin diseases - Google Patents

Compositions for topical treatment of skin diseases

Info

Publication number
ZA898605B
ZA898605B ZA898605A ZA898605A ZA898605B ZA 898605 B ZA898605 B ZA 898605B ZA 898605 A ZA898605 A ZA 898605A ZA 898605 A ZA898605 A ZA 898605A ZA 898605 B ZA898605 B ZA 898605B
Authority
ZA
South Africa
Prior art keywords
compositions
skin diseases
topical treatment
topical
treatment
Prior art date
Application number
ZA898605A
Other languages
English (en)
Inventor
John Arthur Mclane
Arthur Mclane John
Milan Radoje Uskokovic
Radoje Uskokovic Milan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA898605B publication Critical patent/ZA898605B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
ZA898605A 1988-11-14 1989-11-10 Compositions for topical treatment of skin diseases ZA898605B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/270,983 US5021451A (en) 1988-11-14 1988-11-14 Method for inhibiting hyperproliferative diseases

Publications (1)

Publication Number Publication Date
ZA898605B true ZA898605B (en) 1990-07-25

Family

ID=23033693

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898605A ZA898605B (en) 1988-11-14 1989-11-10 Compositions for topical treatment of skin diseases

Country Status (9)

Country Link
US (1) US5021451A (xx)
EP (1) EP0369263A3 (xx)
JP (1) JPH02180847A (xx)
AU (1) AU635906B2 (xx)
CA (1) CA2002715A1 (xx)
DK (1) DK565089A (xx)
NZ (1) NZ231353A (xx)
PH (1) PH27006A (xx)
ZA (1) ZA898605B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5547988B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
US5834510A (en) * 1986-12-23 1998-11-10 Tristrata Technology, Inc. Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
US6376476B1 (en) * 1996-12-13 2002-04-23 Zymogenetics Corporation Isoprenoid pathway inhibitors for stimulating bone growth
US6191167B1 (en) 1997-12-29 2001-02-20 Tristrata Technology, Inc. Pharmaceutical compositions containing hydroxycarboxylic acid and/or ketocarboxylic acids and methods of using the same
CO5140104A1 (es) * 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
FR2801508B1 (fr) * 1999-11-29 2003-11-14 Oreal Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee
US20030017181A1 (en) * 2001-05-31 2003-01-23 Rood Gloria A. Dermatological compositions and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294926A (en) * 1979-06-15 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors

Also Published As

Publication number Publication date
EP0369263A3 (de) 1990-12-27
DK565089D0 (da) 1989-11-10
NZ231353A (en) 1993-04-28
DK565089A (da) 1990-05-15
US5021451A (en) 1991-06-04
JPH02180847A (ja) 1990-07-13
AU635906B2 (en) 1993-04-08
PH27006A (en) 1993-02-01
CA2002715A1 (en) 1990-05-14
AU4464089A (en) 1990-05-17
EP0369263A2 (de) 1990-05-23

Similar Documents

Publication Publication Date Title
IL83925A0 (en) Compositions for treatment of skin disorders
EP0513862A3 (en) Use of topical applicable preparation for treating skin aging
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU6747887A (en) Treatment of skin disorders
ZA898605B (en) Compositions for topical treatment of skin diseases
EP0330496A3 (en) Skin treatment composition
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
ZA874251B (en) Therapeutic agent for skin ulcers
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
GB2183156B (en) Composition for treating skin disease
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
AU591107B2 (en) Psoralene-based bath compositions for treatment of skin disorders
GB8804531D0 (en) Skin treatment formulations
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
GB2093345B (en) A topical use composition for the treatment of seborrhea affections of the human scalp
AU1306388A (en) Preparation for treatment of skin disorders
IL93030A0 (en) Composition containing thymo-pentin for topical treatment of skin disorders
GB8806116D0 (en) Treatment of skin diseases
ZA97253B (en) Topical compositions for the treatment of skin diseases
ZA936136B (en) Treatment of skin diseases
GB8611588D0 (en) Treatment of skin diseases
GB8514096D0 (en) Treatment of skin diseases
IE891002L (en) Topical preparations for treatment of presbyderma
IE852526L (en) Composition for treatment of skin
GB8714855D0 (en) Skin treatment compositions